Roberto Faggiuolo

2.3k citations
27 papers · 1.9k · 1 hit paper · h-index 13

Impact in

  • Oncology top 2%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Surgical Treatments
    • Pancreatic and Hepatic Oncology Research
  • Hepatology top 5%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • HER2/EGFR in Cancer Research 4
    • Cancer Treatment and Pharmacology 3
    • Cancer Diagnosis and Treatment 3
    • Colorectal Cancer Treatments and Studies 3
    • Peptidase Inhibition and Analysis 3
    • Thyroid Disorders and Treatments 3

Roberto Faggiuolo

25 papers receiving 1.8k citations

Roberto Faggiuolo's Hit Papers

Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer 2000 · 1.2k citations
1.2k0+8+17Years since publication2505007501000

Peers

Roberto Faggiuolo
Comparison fields: 5 of 91
  • Oncology 1.2k
  • Hepatology 282
  • Endocrine and Autonomic Systems 126
  • Pathology and Forensic Medicine 185
  • Pulmonary and Respiratory Medicine 238
Replace Jean-Michel Vannetzel with:
Jean-Michel Vannetzel France
Moshe Itzhaki France
Jean–Louis Formento France
Julio Gastiaburu France
Roberto Salgado Belgium
Felix W.M. de Rooij Netherlands
Sonali Jindal United States
Glenn Scott Kroog United States
Jean-Michel Foidart Belgium
Maria E.L. van der Burg Netherlands
Roberto Faggiuolo relative to Jean-Michel Vannetzel France Jean-Michel Vannetzel's profile →
Citations per field
00.5×2×4×5.2×
Jean-Michel Vannetzel · 1×
Citations per year

Countries citing papers authored by Roberto Faggiuolo

Since Specialization
Citations

This map shows the geographic impact of Roberto Faggiuolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Faggiuolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Faggiuolo more than expected).

Fields of papers citing papers by Roberto Faggiuolo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Faggiuolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Faggiuolo. The network helps show where Roberto Faggiuolo may publish in the future.

Co-authors

The 25 scholars most cited alongside Roberto Faggiuolo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roberto Faggiuolo Line = papers co-authored together Roberto Faggiuolo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer
Hit paper breakdown →
20001175
2 1994343
3 199772
4 200742
5 200540
6 200437
7 200336
8 199026
9 200521
10 199220
11 200620
12 200515
13 198314
14 199012
15 19849
16
Melatonin relationship to human tumors
19875
17 19955
18 20055
19 19954
20 20084

About Roberto Faggiuolo

Roberto Faggiuolo is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine, Surgery and Endocrine and Autonomic Systems, having authored 27 papers that have together received 1.9k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (4 papers), Cancer Treatment and Pharmacology (3 papers), Cancer Diagnosis and Treatment (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Peptidase Inhibition and Analysis (3 papers), Thyroid Disorders and Treatments (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Oncology (1.2k citations), Hepatology (282 citations), Endocrine and Autonomic Systems (126 citations), Pathology and Forensic Medicine (185 citations) and Pulmonary and Respiratory Medicine (238 citations). Roberto Faggiuolo has collaborated with scholars based in Italy and France. Frequent co-authors include Francis Albert Lévi, Rachid Zidani, Bruno Perpoint, Philippe J. M. Chollet, Sylvie Giacchetti, Bruno P. Coudert, Christian Focan, R. Adam, Nathalie Le Bail and Jean Louis Misset. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Oncology, Acta Oncologica and Annals of the New York Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact